MORF-720

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMORF-720
Drug Alias NameMORF-720
ClassificationSmall molecules
Mechanisms of ActionIntegrin alpha-V/beta-6 antagonists
TargetsIntegrin alpha-V/beta-6
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical SchoolMorphic Therapeutic Inc
China Registration ClassN/A

Develop Information

Active CompaniesMorphic Therapeutic IncAbbvie LtdHarvard Medical School
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A